UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$622M |
| 2 |
Mondelez International
MDLZ
|
+$579M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$418M |
| 4 |
Deutsche Bank
DB
|
+$340M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
NXP Semiconductors
NXPI
|
+$533M |
| 3 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$383M |
| 4 |
Hilton Worldwide
HLT
|
+$340M |
| 5 |
CERN
Cerner Corp
CERN
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.75% |
| 2 | Healthcare | 6.75% |
| 3 | Technology | 6.26% |
| 4 | Industrials | 5.06% |
| 5 | Consumer Discretionary | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Coherus Oncology
CHRS
$194M
| $171K | ﹤0.01% |
11,837
+9,107
| +334% | +$175K |
|
4802
Red Rock Resorts
RRR
$3.68B
| $171K | ﹤0.01% |
7,260
-1,438
| -17% | -$33.5K |
|
|
CYRN
4803
DELISTED
CYREN Ltd.
CYRN
| $170K | ﹤0.01% |
+4,136
| New | +$171K |
|
4804
AudioCodes
AUDC
$252M
| $169K | ﹤0.01% |
28,160
+14,509
| +106% | +$94.5K |
|
4805
York Water
YORW
$512M
| $169K | ﹤0.01% |
4,860
+339
| +7% | +$11.9K |
|
4806
CALL
Pan American Silver
PAAS
$20.2B
| $168K | ﹤0.01% |
10,000
| – | – |
|
|
PHX
4807
DELISTED
PHX Minerals
PHX
| $168K | ﹤0.01% |
7,270
-382
| -5% | -$7.77K |
|
4808
ProShares Ultra Semiconductors
USD
$2.85B
| $168K | ﹤0.01% |
100,800
-30,720
| -23% | -$53K |
|
|
APF
4809
DELISTED
Morgan Stanley Asia Pacific Fund
APF
| $168K | ﹤0.01% |
10,104
+5,003
| +98% | +$80.4K |
|
|
ARLZ
4810
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $168K | ﹤0.01% |
124,530
+117,910
| +1,781% | +$170K |
|
|
AMWD
4811
DELISTED
American Woodmark
AMWD
| $167K | ﹤0.01% |
1,746
-19,318
| -92% | -$1.77M |
|
|
HIND
4812
Vyome Holdings
HIND
$15M
| – | – |
0
| – | – |
|
4813
ProShares Ultra MSCI Brazil Capped
UBR
$3.8M
| $167K | ﹤0.01% |
2,949
+2,336
| +381% | +$149K |
|
|
GCH
4814
DELISTED
Aberdeen Greater China Fund
GCH
| $167K | ﹤0.01% |
14,583
+8,196
| +128% | +$89.1K |
|
4815
PUT
First Majestic Silver
AG
$8.52B
| $166K | ﹤0.01% |
20,000
| – | – |
|
4816
Codexis
CDXS
$159M
| $166K | ﹤0.01% |
30,413
+28,553
| +1,535% | +$131K |
|
4817
Viasat
VSAT
$11.3B
| $166K | ﹤0.01% |
2,512
+724
| +40% | +$47.6K |
|
4818
John Wiley & Sons Class B
WLYB
$2.76B
| $166K | ﹤0.01% |
3,142
+392
| +14% | +$20.6K |
|
|
MNP
4819
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
| $166K | ﹤0.01% |
10,620
+1,385
| +15% | +$21.7K |
|
4820
PUT
Ameriprise Financial
AMP
$49.5B
| $165K | ﹤0.01% |
1,300
+1,000
| +333% | +$127K |
|
4821
Cimpress
CMPR
$2.34B
| $165K | ﹤0.01% |
1,746
-4,609
| -73% | -$407K |
|
4822
CALL
Ares Capital
ARCC
$14.1B
| $164K | ﹤0.01% |
10,000
| – | – |
|
|
FUND
4823
Sprott Focus Trust
FUND
$304M
| $164K | ﹤0.01% |
22,231
+576
| +3% | +$4.32K |
|
4824
WisdomTree New Economy Real Estate Fund
WTRE
$15.7M
| $164K | ﹤0.01% |
5,587
+4,901
| +714% | +$145K |
|
|
TIVO
4825
DELISTED
Tivo Inc
TIVO
| $164K | ﹤0.01% |
8,785
-62,296
| -88% | -$1.13M |
|
Similar funds
UBS Group's Q2 2017 Portfolio in Review
As of Q2 2017, UBS Group held 8,497 positions worth $193B, up 5.4% from $183B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2017 filing shows 756 new, 3,610 increased, 2,944 reduced and 742 closed positions. Its largest new stake was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.
- UBS Group's largest Q2 2017 buy was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M.
- UBS Group added most to Monsanto Co in Q2 2017, an estimated $622M increase.
- UBS Group's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- UBS Group fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $383M.
- UBS Group's ten largest holdings make up 13% of its $193B portfolio in Q2 2017.
- UBS Group opened 756 new positions and closed 742 in Q2 2017.
- UBS Group's portfolio value rose 5.4% quarter-over-quarter to $193B.
Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.